Literature DB >> 27563392

Targeting the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein for the Treatment of Cystic Fibrosis.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2016        PMID： 27563392      PMCID： PMC4983730          DOI： 10.1021/acsmedchemlett.6b00258

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization.

Authors:  P Andrew Chong; Patrick J Farber; Robert M Vernon; Rhea P Hudson; Anthony K Mittermaier; Julie D Forman-Kay
Journal:  J Biol Chem       Date:  2015-07-06       Impact factor: 5.157

Review 2.  Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?

Authors:  Ashley Heard; Jake Thompson; Jessica Carver; Michelle Bakey; X Robert Wang
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 3.  Targeting ion channels in cystic fibrosis.

Authors:  Marcus A Mall; Luis J V Galietta
Journal:  J Cyst Fibros       Date:  2015-06-23       Impact factor: 5.482
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.